Therma Bright AI Stock Analysis
Want to see TSE:THRM full AI Analyst Report?
Therma Bright (THRM) AI Stock Analysis
Therma Bright
(TSXV:THRM)
Therma Bright scores near the bottom of the range, driven primarily by severe financial weakness: negative stockholders' equity, an asset base of just ~$218K, and large losses relative to essentially no revenue, all pointing to significant going-concern and dilution risk. Technicals reinforce the caution, with the stock trading below all major moving averages and a negative MACD confirming a downtrend. Valuation provides no offset given negative earnings and no dividend. The only mitigating factors are a sharply reduced cash burn and revenue growth from a near-zero base, which are insufficient to change the highly speculative profile. Earnings call and corporate event components were excluded due to lack of data, with their weight redistributed proportionally.
Therma Bright (THRM) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 979.95K
- Dividend Yield
- ―
- Average Volume (3M)
- 39.77K
- Price to Earnings (P/E)
- -0.5
- Beta (1Y)
- 1.33
- Revenue Growth
- 233.67%
- EPS Growth
- -3.63%
- Country
- Canada
- Employees
- 5
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Devices
Therma Bright Business Overview & Revenue Model
Company Description
Established in Toronto, Canada, in 2001 as The Jenex Corporation before rebranding to Therma Bright Inc. in February 2018, Therma Bright Inc. specializes in creating and distributing various medical and consumer health products. Their diverse offerin...
How the Company Makes Money
Therma Bright makes money primarily by selling its medical and screening products and related solutions to customers (e.g., through direct sales and distribution channels). Reported revenue is generally tied to (1) product sales (hardware such as inf...
Therma Bright Financial Statement Overview
Summary
Financials are exceptionally weak across all three statements. Revenue is negligible (~$136K TTM) against a ~$4.0M net loss, producing a net margin near -2,952% and volatile gross margins. The balance sheet has deteriorated into negative stockholders' equity (-$1.93M) with total assets of only ~$218K, raising serious going-concern risk. Cash flow remains negative (-$217K TTM operating and free cash flow), though burn has decelerated sharply from prior years. Modest positives — triple-digit revenue growth off a tiny base and reduced cash burn — are far outweighed by the near-total erosion of the asset and equity base and the likely need for dilutive financing.
Income Statement
12Very NegativeBalance Sheet
8Very NegativeCash Flow
15Very Negative| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 135.82K | 80.27K | 26.07K | 23.90K | 139.43K | 3,883 |
| Gross Profit | 66.60K | -36.93K | 25.46K | 23.90K | 63.48K | 3,883 |
| EBITDA | -3.98M | -4.25M | -2.34M | -3.68M | -5.73M | -8.55M |
| Net Income | -4.01M | -4.34M | -2.45M | -3.77M | -5.88M | -8.61M |
Balance Sheet | ||||||
| Total Assets | 217.95K | 248.69K | 3.19M | 2.21M | 4.00M | 2.24M |
| Cash, Cash Equivalents and Short-Term Investments | 25.13K | 38.07K | 1,096 | 182.24K | 3.08M | 1.78M |
| Total Debt | 40.00K | 40.00K | 65.39K | 90.39K | 110.55K | 40.00K |
| Total Liabilities | 2.15M | 1.81M | 1.87M | 2.16M | 1.25M | 927.12K |
| Stockholders Equity | -1.93M | -1.57M | 1.32M | 44.79K | 2.75M | 1.32M |
Cash Flow | ||||||
| Free Cash Flow | -217.40K | -146.53K | -1.01M | -2.44M | -3.80M | -3.16M |
| Operating Cash Flow | -217.40K | -146.53K | -1.01M | -2.17M | -3.80M | -2.86M |
| Investing Cash Flow | 0 | 0 | -138.26K | -691.08K | -204.93K | -300.00K |
| Financing Cash Flow | 176.82K | 146.90K | 966.40K | -33.60K | 5.31M | 3.87M |
Therma Bright Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:THRM, the sentiment is Neutral. The current price of 0.04 is above the 20-day moving average (MA) of 0.03, below the 50-day MA of 0.04, and below the 200-day MA of 0.05, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 55.84 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:THRM.
Therma Bright Peers Comparison
Overall Rating
TSE:PRN61Neutral
TSE:PINK44Neutral
TSE:TLT41.2Neutral
TSE:ASTI40Underperform
TSE:THRM39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 61Neutral | CAD 349.42M | -7.23 | -59.18% | ― | 64.70% | 30.61% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 44Neutral | CAD 20.71M | -1.03 | -303.05% | ― | 35.27% | 58.34% | |
| 41Neutral | CAD 57.44M | -13.03 | -130.04% | ― | -24.86% | 18.29% | |
| 40Underperform | CAD 275.99K | -0.18 | 23.95% | ― | 8.66% | -545.88% | |
| 39Underperform | CAD 2.14M | -0.51 | 234.23% | ― | 233.67% | -3.63% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:THRM | Therma Bright Inc. | 0.04 | -0.03 | -46.15% | |
| TSE:PINK | Perimeter Medical Imaging Ai Inc | 0.14 | -0.04 | -25.00% | |
| TSE:PRN | Profound Medical | 9.54 | 1.17 | 13.98% | |
| TSE:TLT | Theralase Technologies | 0.18 | 0.00 | 0.00% | |
| TSE:ASTI | Aquarius Surgical Technologies | 0.01 | 0.00 | 0.00% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 29, 2026
